WiseOmni Platform

Enterprise AIDD AI Agent Infrastructure

Empowering every pharmaceutical company, Biotech, and CDMO with a 24/7 AI R&D team

AIDD: From "Tool Era" to "Agent Era"

About Us

AIDD is undergoing a paradigm shift from "tools" to "agents." Foundation models like AlphaFold2 and Boltz have achieved remarkable capabilities, yet most pharmaceutical companies still struggle to use them directly—they require specialized personnel, are difficult to integrate into workflows, and cannot accumulate enterprise knowledge.

We build private AIDD AI agent infrastructure for every pharmaceutical company, Biotech, and CDMO. Not scattered tools, but a 7×24 online AI R&D team that continuously learns from enterprise data and deeply integrates into R&D processes. Data is physically isolated and fully owned by you.

Our Mission: Enable every pharmaceutical company to have its own dedicated AIDD AI agent team, making drug discovery faster, more accurate, and more economical.

Our Products

WiseOmni Platform — Enterprise-grade AIDD AI agent platform with four core components

WiseAgent — AI Agent Interaction Hub

Natural language-driven R&D assistant enables researchers to complete complex tasks like protein structure prediction, molecular generation, and affinity analysis through conversation. Features autonomous task planning and execution, understanding complex R&D objectives, breaking down task steps, and completing end-to-end workflows.

WiseKB — AIDD Domain Knowledge Base

Integrates multi-source information including public literature, patent data, experimental records, and internal reports to build a unified knowledge graph. Based on RAG and chemical structure search technologies, enables cross-document intelligent Q&A and knowledge reasoning, continuously updating with enterprise data accumulation to form exclusive knowledge assets.

WiseDB — R&D Data Asset Management Platform

Unified data model designed for AIDD scenarios, supporting multiple data types including compounds, proteins, experimental data, and computational results. Complete data lineage tracking ensures traceability and auditability. Helps enterprises establish data governance systems, transforming scattered R&D data into reusable strategic assets.

WiseModel — AIDD Model Service Engine

Pre-integrates mainstream open-source AIDD models including AlphaFold2, Boltz-1/2, Boltz-Gen, RFdiffusion, and ESMFold. Adopts a dual-layer architecture of general models + exclusive models: general models are continuously optimized and updated, while exclusive models are trained on enterprise private data, becoming increasingly attuned to your business.

Solutions

Tailored AIDD AI agent solutions for different types of pharmaceutical companies

Innovative Biotech Companies

Computational biology talent is scarce, and reliance on external CROs poses data security risks. WiseOmni Platform provides out-of-the-box AIDD capabilities, enabling industry-leading computational biology expertise without large-scale recruitment of specialized talent. Private deployment ensures core data assets remain secure and controllable.

Traditional Pharmaceutical R&D Departments

Established R&D processes, large volumes of historical data with varying quality, and extremely high compliance requirements. WiseOmni provides complete data governance systems and model layering capabilities, helping enterprises gradually unlock the value of historical data assets while achieving progressive AI capability introduction under compliance guarantees.

Production-oriented CDMOs

High barriers to AIDD model deployment, extensive historical R&D documents not yet organized into knowledge systems, rich production data but lacking AI model training. WiseAgent lowers technical barriers, WiseKB and WiseDB establish systematic knowledge management, and WiseModel trains exclusive models to improve production efficiency.

Case Studies

We are building dedicated AIDD AI agent teams for pharmaceutical companies

Case 1: AI Small Molecule Drug Discovery Agent

Deployed a private WiseOmni Platform for an innovative Biotech company, creating a dedicated small molecule drug discovery AI agent. The system continuously learns from the company's compound library and project data, evolving exclusive molecular generation and optimization capabilities, becoming a 24/7 online AI drug design expert within their R&D team.

Case 2: AI Drug Synthesis Agent

Built a drug synthesis AI agent system for a CDMO enterprise, integrating advanced models and training private prediction models. The system operates 7×24 online, providing the R&D team with knowledge base retrieval, retrosynthesis analysis, and other capabilities, significantly improving R&D and production efficiency.

Training & News

Latest training programs and industry updates

Contact Us

Email:

info@wise-omni.com

Shenzhen Office:

C1118 Innovation Plaza, No. 2007 Pingshan Avenue, Pingshan District, Shenzhen

Hong Kong Office:

Hong Kong Science and Technology Park

Greater Bay Area Service:

Serving clients across Hong Kong, Macao and Mainland China

WeChat Official Account: